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Abstract   
Western-type diet (WD) is a risk factor for colorectal cancer but the underlying mechanisms 
are poorly understood. We investigated the interaction of WD and heterozygous mutation in 
the Apc gene on adenoma formation and metabolic and immunological changes in the 
histologically normal mucosa of ApcMin/+ (Min/+) mice. The diet used was high in saturated 
fat and low in calcium, vitamin D, fiber and folate. The number of adenomas was twofold 
higher in the WD mice compared to controls, but adenoma size, proliferation or apoptosis 
did not differ. The ratio of the Min to wild-type allele was higher in the WD mice, indicating 
accelerated loss of Apc heterozygosity (LOH). Densities of intraepithelial CD3ε+ T 
lymphocytes and of mucosal FoxP3+ regulatory T cells were higher in the WD mice, implying 
inflammatory changes. Western blot analyses from the mucosa of the WD mice showed 
suppressed activation of the ERK and AKT pathways and a reduced activation of the mTOR 
pathway as measured in phosphoS6/S6 levels. The expression of pyruvate dehydrogenase 
kinase 4 (PDK4) was strongly upregulated in both mRNA and protein levels. Microarray 
analyses showed changes in oxidation/reduction, fatty acid, and monosaccharide metabolic 
pathways, tissue organization, cell fate and regulation of apoptosis. Together, our results 
suggest that the high-risk Western diet primes the intestinal epithelium to tumorigenesis by 
programming a cancer-type energy metabolism, and by inducing metabolic and 
inflammatory oxidative stress, which accelerate LOH of the Apc gene. 
 
Introduction 
Colorectal cancer (CRC) is one of the most common cancer types in industrialized countries. 
An inactive lifestyle, obesity, and a high-fat diet with low micronutrient density are well-
known risk factors for CRC, and studies in various animal models support the role of a high-
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risk Western-type diet, i.e. a diet that is high in fat and low in fiber, calcium, vitamin D and 
folate, in colon tumorigenesis (1-4).  Mechanisms for how the unbalanced, high-energy 
yielding Western-type diet predisposes or promotes the intestinal epithelium to 
carcinogenesis are poorly understood.  
 
Components of the Wnt signaling pathway are almost ubiquitously mutated in CRC, most 
typically the Apc gene, and mutations in the APC gene are found in the majority of sporadic 
CRC cases (5). APC regulates β-catenin pools in cells. Increased nuclear accumulation of β-
catenin is one of the driving forces for colon tumorigenesis (6).  
 
Recent research connects the activation of Wnt signaling with dysregulation of energy 
metabolism so that its activation drives increased use of glucose, i.e. Warburg-type cancer 
metabolism (7). Increased glycolytic rate in transformed cells elevates the production of 
glycolytic intermediates, which are used in the biosynthetic pathways to satisfy the anabolic 
needs of dividing cells (8). This provides a selective growth advantage for transformed cells. 
Furthermore, mitochondrial metabolism is shifted to uncoupled oxidation of glutamine and 
fatty acids to maintain glycolysis. These alterations in cellular metabolism predispose cells to 
an increased load of reactive oxygen species that activate apoptosis or, if the cell does not 
undergo apoptosis, may induce tumorigenic proliferation and anchorage-independent 
growth (9). Earlier it was believed that the Warburg effect is secondary to transformation, 
but the metabolic changes seem to occur already during the transformation process and are 
governed by the same signal transduction pathways as proliferation (10). Interestingly, an 
earlier study (4) demonstrated that a Western-type diet reprograms the intestinal 
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epithelium towards a gene expression pattern resembling that driven by Apc mutations. 
Thus, dietary and genetic factors converge in driving intestinal tumorigenesis.  
In the glycolytic switch, pyruvate dehydrogenase kinases (PDKs) act as key regulators. These 
inactivate the pyruvate dehydrogenase complex, which catalyzes the rate-limiting step for 
channeling pyruvate into the tricarboxylic acid cycle. Increased PDK4 expression has been 
reported in preneoplastic intestinal epithelium of cancer-susceptible mice and CRC patients. 
In addition, it is known that PDK inhibition can suppress tumor growth (11, 12). On the other 
hand, many tumors show lower PDK4 expression in comparison to the normal tissue of 
origin, indicating that the metabolic demands in the various stages of carcinogenesis are 
different (13). PDK4 expression is negatively regulated by the PI3 kinase/AKT and ERK1/2 
pathways, which control nutrient uptake and convey growth factor signals to the mTOR 
kinase, promoting cellular growth and differentiation (13, 14). These pathways are 
commonly overactivated in CRC and other cancers (15, 16).  
 
We have earlier shown that high fat content in an otherwise balanced diet does not 
promote intestinal tumorigenesis in the Apc –mutated Min/+ mouse (17), a widely used 
murine model of human intestinal carcinogenesis. Here we have further studied tumor 
formation in the Min/+ mouse by combining the high fat content with marginal 
concentrations of fiber, calcium, vitamin D and folate to better mimic a typical Western-type 
diet. Several of these components have been shown to interact with β-catenin metabolism 
(18-20).  
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We found that the high-risk Western-type diet accelerated adenoma formation, but not 
growth, in the Min/+ mouse.  Increases in adenoma numbers were accompanied by loss of 
heterozygosity (LOH) in the Apc gene, downregulation of ERK1/2, AKT and mTORC1 
signalling pathways, as well as changes in the density of immune cells in the normal 
appearing mucosa of the Min/+ mouse. Microarray analyses showed several changes in the 
key cellular pathways regulating energy metabolism, tissue organization and cell fate, all of 
which could predispose the intestinal epithelium to enhanced tumorigenesis. 
 
Materials and Methods 
Animals and diets 
Male and female C57BL/6J Min/+ mice were bred at the Laboratory Animal Centre in Viikki, 
Helsinki, from inbred mice originally obtained from the Jackson Laboratory (Bar Harbor, ME, 
USA). After weaning, the mice were PCR screened for the Min/+ genotype. The 5-week old 
Min/+ mice were stratified by weight and litter background and assigned into experimental 
diets. The mice were housed in plastic cages in humidity- and temperature-controlled 
facilities with a 12-h light-dark cycle. They were fed ad libitum and had free access to tap 
water. The mice were weighed and monitored weekly and a record was kept on their growth 
throughout the experiment.  One mouse from the WD group had to be sacrificed before the 
end of the experiment due to considerable weight-loss during one week and was 
consequently excluded from the subsequent analyses.  The total number of mice included in 
the data was 12 in the WD diet group and 14 in the control diet group. The control diet was 
the semisynthetic unmodified AIN-93G diet. The WD was modified from AIN-93G, with high 
fat and low fiber, vitamin D, calcium and folate (Table I; Harlan Teklad, Madison, WI). We 
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used our own modification of the Western-type diet, which highly resembles the New 
Western Diet (NWD) used by Newmark et al (2). shown to induce benign and malignant 
neoplasms in the colon of normal B6 mice after an 18 month feeding experiment The main 
difference between NWD and our WD is the source of fat, which in our diet resembled the 
more typical consumption of fat in Western populations, and was largely composed of milk 
fat (66.4% of total fat from milk, and 33.6% from rapeseed and sunflower oil) while in the 
NWD the main fat source was corn oil.  The Laboratory Animal Ethics Committee, University 
of Helsinki approved the study protocol. 
 
Evaluation of adenomas and collection of samples 
After the 10-week feeding period, the mice were sacrificed by CO2 asphyxiation.  Blood was 
collected from the abdominal aorta and after centrifugation the plasma was stored at -70oC. 
The small intestine, caecum and colon were removed and opened along the longitudinal axis 
and rinsed with ice-cold saline. The small intestine was divided into five sections of equal 
length. The caecum and colon were separated from the small intestine and kept together for 
analysis. The intestinal sections were spread flat on microscope slides. Each section of the 
intestine and colon and caecum was analyzed under a stereomicroscope attached to a 
monitor. The number and diameter of each adenoma was recorded for all intestinal sections 
separately. The observers keeping record were blinded to the treatment. The intestinal 
adenomas were excised from the tissue and the normal-appearing mucosa that was left 
behind was scraped off from lamina propria. The tissue samples were snap frozen in liquid 
nitrogen and stored at -70oC. For immunostaining analyses, samples were collected from the 
distal small intestine, fixated in buffered 4% paraformaldehyde and processed for paraffin 
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sections. For microarray analysis, another 0.5 cm section was collected from the same 
intestinal area and stored in RNA later solution (Qiagen) at -20 oC.  
 
Immunostaining 
Paraffin tissue sections were deparaffinised and subjected to heat-induced antigen retrieval 
(microwave heating for 15 min at 700W power in 250 ml of buffer, followed by a 20 min 
cooling period). Automated immunostaining was performed using the LabVision Autostainer 
480 and the Ultravision detection system (LabVision, Thermo Fisher Scientific). Proliferating 
cells were identified with an antibody against Ki67 antigen (clone SP6, Labvision), mitotic 
cells with anti-phospho-histone H3 (#06-570, Millipore), apoptotic cells with an antibody 
against cleaved caspase 3 (#CP229, Biocare), T lymphocytes with anti-CD3ε (clone SP7, 
Neomarkers), regulatory T cells with anti-FoxP3 (clone FJK16s, eBioscience) and B 
lymphocytes with anti-CD45R (clone RA3-6B2, Invitrogen). Antigen retrieval was performed 
using Na-citrate buffer, pH 6, for all markers except for cleaved caspase 3, where Tris-HCl-
EDTA, pH8 was used. The immunostained sections were photographed using a Leica 
DM4000 microscope and an Olympus DP70 camera. The digital photomicrographs were 
analysed using ImageJ.  
 
Western blotting  
Samples were prepared as described previously (21). Briefly, proteins were isolated from 
morphologically normal mucosa of the distal small intestine, representing approximately 
40% of the total small intestine. For proteinase and phosphatase inhibition, 0.4 mM 
leupeptin, 3.0 µM pepstatin and 1.0 mM PMSF (in DMSO), 0.5 M NaF and Na3VO4 were 
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added to the homogenisation buffer (20 mM Tris-HCl, pH 7.4; 2 mM EDTA; 10 mM EGTA; 
0.25 M saccharose). For the whole mucosa lysate, 10% triton-x was added to the 
homogenate, after which the sample was mixed for 20 minutes with 5 minutes intervals, 
followed by centrifugation (15 000 x g 10 minutes at 4oC). All protein samples were stored at 
-70oC.  Protein samples were loaded in equal concentrations to SDS-PAGE gels (6.5% gels for 
beta-catenin and AKT/phospho AKT, 10% gels for others). All samples were analyzed at least 
as duplicates. An internal standard was used in each gel to control interassay variation. After 
electrophoresis the proteins were transferred to either nitrocellulose (Hybond ECL 
membrane, Amersham Pharmacia Biotech.) or PVDF (Hybond P membrane, Amersham 
Pharmacia Biotech.) membrane. Membranes were incubated overnight in blocking solution 
containing 3.5% non-fat soya (β-catenin and lamin B analysis) or 5% non-fat milk (other 
analyses) in Tris-buffered saline with 0.1% Tween.  Membranes were incubated with primary 
antibodies for 2 hours or overnight with phospho-specific antibodies. Primary antibodies 
were anti-β-catenin (sc-7199, Santa Cruz Biotechnology), anti-phospho-β-catenin (Ser552 
#9566 and Ser675 #4176, Cell Signaling Technology), anti-ERK1 (sc-94, Santa Cruz 
Biotechnology), anti-phospho-p44/42 (#9101, Cell Signaling Technology), anti-AKT (#9272, 
Cell Signaling Technology), anti-phospho-AKT (#9271, Cell Signaling Technology), anti-S6 
(#2217, Cell Signaling Technology), anti-phospho-S6 (#4858, Cell Signaling Technology), anti-
PDK4 (NBP1-07047, Novus Biologicals), anti-lamin B (sc-6216, Santa Cruz Biotechnology), 
and anti-β-actin (A541, Sigma). For protein detection, secondary antibodies (sc-2030 and sc-
2031, Santa Cruz Biotechnology) and enhanced chemiluminescence reagents ECL or ECL+ 
(GE Healthcare) were used. The levels of phosphorylated and total protein were analyzed 
using the same membrane. After incubating the membrane with a phospho-specific 
antibody, the membrane was stripped in stripping buffer (78 mM Tris-HCl, 2% SDS, 0.68% 
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(V/V) mercaptoethanol) for 20 minutes at 65oC, followed by incubation in TBS-Tween for 20 
minutes at 65oC and incubation in TBS-Tween for 20 minutes at room temperature.  Blots 
were transferred to X-ray film (Amersham) and scanned and analyzed by GSA-800 Calibrated 
Imaging Densitometer and Quantity One Program (BioRad Laboratories). β-actin and lamin B 
were used to control equal loading of protein samples. Phosphorylated forms of β-catenin 
and PDK4 were detected using Odyssey infrared imager as described by Marttinen et al. 
(21). 
 
DNA isolation and analysis of loss-of-heterozygosity by qPCR 
Genomic DNA was extracted from histologically normal mucosa of the distal small intestine 
using the DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA). 
 
The relative copy numbers of Min and wild-type Apc alleles in these genomic DNA samples 
were quantified by multiplex quantitative PCR, using the following primers and allelic 
discrimination probes: forward primer, 5’-GACAGTTCTCGTTCTGAG-3’; reverse primer, 5’- 
GTTGGATGGTAAGCACTG-3’; wild-type probe, 5’-[FAM] ctctcTccAaaCttCtgt [BHQ1]-3’; Min 
probe, 5’-[CY3] ctctcTccTaaCttCtgt [BHQ2]-3’. Locked nucleic acid (LNA) nucleotides were 
used in the probes to increase specificity and are indicated in the probe sequences in capital 
letters. The LNA probes were designed and synthesized by Sigma Aldrich. The amplification 
was carried out using the Maxima Probe qPCR Master Mix (Life Technologies) and a 
Stratagene MX3005P qPCR instrument (Agilent Technologies). The cycling conditions were: 
an initial denaturation at 95°C for 15 min, followed by 40 cycles of 95°C for 10 s and 61°C for 
30 s. 
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To obtain the actual ratio of Min and wild-type sequences in each sample, fold changes 
relative to reference DNA samples from Min/+ and wild-type mice were first calculated for 
the Min and wild-type probes, respectively. The ratio of these values was then compared to 
a standard curve obtained from known dilutions of Min/+ and wild-type DNA. The final 
results are averages of three separate parallel qPCR experiments. Individual measurements 
deviating more than 25% from the average of the three parallel runs were excluded from 
subsequent analyses (6% of all measurements).  
 
RNA isolation and gene expression analyses 
Total RNA was extracted from histologically normal-appearing mucosa of the distal small 
intestine using the RNeasy Mini kit (Qiagen). RNA was quantified using the Nanodrop 1000 
spectrophotometer (Thermo Scientific), and the integrity of the RNA samples was verified 
using Bioanalyzer 2100 (v2.6, Agilent Technologies, Inc.). Equal amounts of total RNA was 
taken from each mouse to make 8 pooled samples (2 samples per diet and per sex, 
containing 1-3 mice per sample). The quality of the pooled RNA samples was again 
controlled by Bioanalyzer (RIN >8). The pooled samples were then analyzed by Agilent 
Whole Mouse Genome 4x44K microarray assay. The labeling, hybridization and scanning 
were performed at the Biomedicum Functional Genomics Unit, University of Helsinki.  
 
Statistical analysis 
The non-parametric Mann-Whitney U-test was used to compare the data between the 
groups. The associations between variables were analyzed with the non-parametric 
Spearman’s correlation test. All statistical analyses were performed using the PASW Statistic 
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18 for Windows software (SPSS Inc.). The p-value of P< 0.1 was conceded as a significant 
difference between the groups from Western blot analyses. 
 
The gene-expression microarray data was analyzed with the CSC Chipster v1.4.6 software 
(http://chipster.csc.fi/). The data was normalized using mean normalization, and genes with 
detectable expression in four chips were used in further analyses. Genes with changes ±1.2 
and P < 0.05 were considered differentially expressed. The functional enrichment analyses 
were conducted with DAVID (22, 23). The data sets were reviewed and passed the following 
quality controls: The lists contained many important genes as expected for the study, the 
number of genes was reasonable, in range of few hundred genes in each list, the genes 
passed statistical thresholds (FC 1.2, P<0.05) so that the threshold would not have to be 
sacrificed (e.g., fold changes ≥1.1 and P-value ≤0.2) to reach a comfortable gene size, and 
notable portion of up- or down-regulated genes were involved in certain interesting 
biological processes, such as energy metabolism and Wnt signaling. The lists of enriched 
functional pathways were compared between the lists. The analysis of large gene lists is an 
exploratory, computational procedure rather than a purely statistical method. In order to 
diminish the effect of false positives, as only a large body of genes with similar functions 
may show a significant result in the enrichment analysis, statistics were applied to detect 
enriched functional categories or pathways associated with the genes regulated by the WD 
feed, using Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7 
(23).  
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Results 
Adenoma formation and loss of heterozygosity (LOH) of the Apc gene was increased in 
Min/+ mice consuming WD 
The average number of adenomas in the total small intestine was two times higher in the 
Western-type diet (WD) mice (median 36; range 14-76) compared to the control mice (Fig. 
1A; median 18; range 7-38; P = 0.003). Colon or caecum adenomas were rare and there was 
no difference between the groups. The average size of the adenomas did not differ between 
the groups (Fig. 1B; P = 0.781). Neither was there any difference in the weight gain between 
the diet groups. 
 
Loss of APC heterozygosity was analyzed by allele-specific quantitative PCR in genomic DNA 
isolated from tissue samples from the distal part of the small intestine. The ratio of the Min 
allele to the wild-type allele was significantly higher in the WD mice (Fig.1C; P = 0.026), 
suggesting that the high risk WD accelerated LOH. LOH was associated with adenoma 
number in the total small intestine (Fig. 1D; rs = 0.573, P = 0.03). 
 
Mucosal β-catenin, proliferation and apoptosis were not changed in the WD mice 
Levels of total β-catenin were analyzed from whole mucosa lysate and were 7.85 (median, 
min 2.48 max 14.6) in the WD mice compared to 5.54 (median, min 0.58, max 11.93) in the 
control group. The difference, however, was not significant (P = 0.118). The Ser552 and 
Ser675 -phospho-β-catenin in nuclear fractions were also measured. The Ser552-phospho-β-
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catenin showed a similar non-significant trend for increased nuclear accumulation, as did 
the total β-catenin (data not shown).  
 
Epithelial proliferation was assessed in the mucosa by the average height of the Ki67 antigen 
positive zone, measured from the crypt bases, and by the number of mitotic (phospho-
histone H3 positive) cells per crypt zone mm2. The rate of apoptosis was measured by 
counting cleaved caspase 3 positive cells per mucosa mm2. Proliferation and apoptosis did 
not differ between the groups (Fig. 2A and B). However, the ratio of proliferation to 
apoptosis was slightly lower in the WD mice compared to the controls (Fig 2C. P = 0.098).  
 
Decrease in the relative activation of mucosal ERK1/2 and AKT pathways in the WD mice 
Phosphorylation of ERK1/2 and AKT were analyzed from whole mucosa lysate from the distal 
part of the intestine. The activation of the ERK pathway was significantly suppressed in the 
WD mice. This was seen in both ERK1 (p44) and ERK2 (p42) phosphoprotein levels (P = 0.036 
and 0.031). When the p42 and p44 protein bands were analyzed together, the relation of 
phosphorylated to total ERK in the WD mice was 1.07 (min 0.07, max 2.82) while it was 3.38 
(min 0.14, max 10.58) in the control mice (Fig. 3A, P = 0.045). No difference was seen in the 
total amount of ERK1 or ERK2 (P = 0.43 and P = 0.59, respectively). The ratio of 
phosphorylated AKT to total AKT showed a tendency to decrease in the WD group (Fig. 3B, P 
= 0.090).  
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Decrease in the relative activation of mucosal mTOR pathway, with increase in PDK4 
protein level in the WD mice 
The WD mice had a reduced activation of the mTOR pathway as measured in pS6/total S6 
levels (medians 0.40 vs. 0.11) (Fig. 3C, P = 0.057). No difference was seen in the total 
amount of S6 between the groups (P = 0.92). The microarray data showed an expression 
level of PDK4 that was nine times higher in the WD mice when compared to the controls. 
Thus, the protein levels for PDK4 were also measured. These were 13.3 and 10.9 (medians, P 
= 0.057) for WD and control diet respectively (Fig. 3D), confirming an upregulation of PDK4 
signaling in the WD mice.  
 
The density of intraepithelial T lymphocytes and mucosal regulatory T cells were higher in 
the WD mice  
The density of intraepithelial CD3ε+ T lymphocytes and the density of mucosal FoxP3+ 
regulatory T cells were significantly higher in the WD mice, while the density of mucosal 
CD45R+ B lymphocytes did not differ significantly between the diet groups (Fig 4A-C; P = 
0.016, 0.027, 0.129, respectively). Adenoma numbers correlated significantly with the 
density of FoxP3+ cells (Fig. 4D; P = 0.006) and inversely with the density of CD45R+ cells (Fig. 
4E; P = 0.011).  
 
Global gene expression analyses revealed several changes in the WD mice 
Global gene expression profiles in the morphologically normal intestinal mucosa were 
analyzed using Agilent Mouse Genome 4 x 44K oligonucleotide arrays.  To gain further 
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insight into the diet-induced changes in gene expression, the data were analyzed for 
enriched pathways and categories. The enriched KEGG and Gene Ontology pathways are 
listed in Tables 2 and 3.  
 
Based on the enrichment analyses, the WD strongly affected energy metabolism in the 
intestinal mucosa: the KEGG pathways, starch and sucrose metabolism, pyruvate 
metabolism, glycolysis/gluconeogenesis and PPAR signaling were significantly different 
between the groups (P < 0.05).  The Gene Ontology analysis showed that several genes 
associated with oxidation/reduction and fatty acid, hexose, glucose and monosaccharide 
metabolic processes were significantly differently expressed between the control and the 
WD groups. Of individual genes, the largest difference between groups was found in the 
expression of PDK4 that was nine times higher in the WD mice when compared to the 
controls. Other significantly up-regulated genes related to glucose metabolism were 
glucose-6-phosphatase and glucosidase, while the expressions of TCA-cycle enzyme 
oxoglutarate dehydrogenase and glycerol phosphate dehydrogenase from oxidative 
phosphorylation were downregulated in the WD mice.  
 
The genes up-regulated in WD mice and related to fatty acid oxidation and oxidative stress 
response included several cytochromes, the acyl-CoA thioesterase Acot12, the acyl-
coenzyme A dehydrogenase AcadI, glutathione and thiol reductases, and vanin-1, a sensor 
of oxidative stress in epithelial cells. The WD had an impact on the regulation of apoptosis 
and cellular death in the intestinal mucosa by modifying the expression of both pro- and 
anti-apoptotic genes, including e.g. up-regulation of angiopoietin-like 4 (Angptl4) and the 
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stem cell marker Bmi1. The WD also affected the Wnt receptor signaling pathway (as 
defined by both KEGG and GO).  Down-regulation of Tcf4 (reported with two probes) 
suggests that Wnt signaling was generally suppressed in the mice consuming WD. 
Interestingly, GO-based analyses revealed that the tissue organization pathway defined by 
e.g. filopodium and microspike assembly, as well as cell projection assembly genes, were 
different between the groups (Table 3).   
 
Discussion 
We studied how a high-risk Western diet affects the development of intestinal cancer in a 
murine model with genetic predisposition to tumorigenesis, the Min/+ mice. The Western 
type diet is expected to induce a metabolic stress due to the high fat content and the low 
content of fiber and several micronutrients. The WD accelerated the initiation of adenomas 
in our study, but did not promote tumor growth, indicating that the diet primarily impacted 
the preneoplastic, histologically normal intestinal epithelium.  
 
In the Min/+ mouse as in the vast majority of human CRC cases the driving force for 
tumorigenesis is an activation of the Wnt pathway due to the mutation in Apc gene. A 
prerequisite for adenoma formation is loss of Apc heterozygosity (LOH) (5). We found an 
increase in the ratio of the Min allele to the wild-type allele in the histologically normal 
intestinal mucosa in Min/+ mice consuming WD. This indicates acceleration of LOH by the 
diet. Furthermore, the LOH results correlated with the numbers of adenomas.  
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LOH occurs primarily by homologous somatic recombination in both human and Min/+ 
adenomas (24). Thus, the increased adenoma formation in WD mice could be partially 
explained by factors that induce recombination, such as oxidative DNA damage (25, 26). The 
oxidative stress induced by increased fatty acid metabolism on a high-fat diet has been 
reported to increase mitochondrial as well as nuclear DNA damage (27, 28). In our WD mice, 
gene expression analysis showed strongly upregulated oxidation/reduction pathways as well 
as oxidative stress responses in the intestinal mucosa, compatible with previous 
observations in the colonic mucosa of WD-fed wild-type mice (29). Oxidative DNA damage 
can also be caused by inflammation (30). We observed an impact of the WD on the 
inflammatory status of the intestinal mucosa. The density of intraepithelial CD3ε+ T 
lymphocytes and of FoxP3+ regulatory T cells was higher and the density of B lymphocytes 
lower in the histologically normal mucosa of the WD mice.  Akeus et al. (31) found an 
accumulation of FoxP3+ regulatory T cells and decreased density of B cells in the adenoma 
tissue of the Min/+ mouse in comparison to wild-type mouse mucosa, indicating that the 
immunological balance in the mucosa of our WD mice had already shifted towards the 
adenoma state.  
 
Our diet was low in calcium and vitamin D, both needed for tight junction physiology. In the 
calbindin-null mice, a calcium and vitamin D deficient diet resulted in down-regulation of 
tight junction genes (32). Tight junction protein expression is regulated through ERK1/2 and 
AKT signaling (33, 34), both of which were clearly down-regulated in our WD mice. Our 
results suggest that low levels of calcium and vitamin D in the diet negatively affect the 
expression of tight junction proteins and, as a result, down-regulate the ERK1/2 and AKT 
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signaling in the WD mice. The microarray expression data showed down-regulation of five 
tight junction genes, casein kinase 2α1, membrane associated guanylate kinase, PKCδ, 
spectrinβ2, and symplekin in the WD mice (data not shown). Downregulation of these genes 
has been shown to promote tumorigenesis in different cancers (35-39). Disruption of the 
tight junction barrier may also explain the inflammatory changes we observed (40). In 
addition, differently expressed tissue organization pathways, filopodium, microspike and cell 
projection assemblies support disturbed tissue or cellular functions in the WD group.   Our 
results are well in line with an earlier study showing that adding calcium and vitamin D 
significantly decreased the number of colonic tumors in a long-term WD feeding experiment 
with wild-type mice (3). In this study, folate did not explain tumor formation. As the folate 
level was the same as in our WD diet, the low folate content probably had no major role for 
adenoma formation in our study either. 
 
The gene expression data and protein-level analyses show that the WD had a profound 
effect on energy metabolism in the intestinal mucosa. PDK4 expression was up-regulated at 
mRNA and protein levels in the WD mice. Together with the activated glucose and fatty acid 
metabolic pathways, these findings suggest that the WD pushed the intestinal mucosa 
towards Warburg-type aerobic glycolysis.  A switch toward oxidative glycolysis, directly 
driven by PDKs, is an early step in cellular transformation.  Shifting to oxidative glycolysis 
enables the cancer cells to acquire building blocks for the proliferation of new cells instead 
of efficient ATP production (8). Glycolysis genes are ubiquitously overexpressed in cancers 
(41). Thus, the glycolytic switch could pre-program the intestinal epithelium to a 
carcinogenesis-compatible metabolic state. In mice consuming a WD, PDK4 may be activated 
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by the high concentrations of free fatty acids, enhanced fatty acid metabolism and up-
regulated PPAR signaling, all of which are known to affect PDK expression (42, 43). The 
decreased Erk signaling is also expected to allow up-regulation of PDK4 expression (13).  
Like the ERK1/2 pathway, also the mTOR signaling was clearly down-regulated. mTOR 
negatively regulates stem cell proliferation and renewal in the intestinal crypts (44). 
Deregulated ribosomal S6K has been linked to disturbed establishment of a stem/progenitor 
population (45). It has also been linked to inhibition of mTOR signalling in cancer cell lines 
with the up-regulated stem cell marker CD133 (46). Our microarray data suggest that the 
stem cell marker Bmi1 was up-regulated in the WD mice. The decreased mTOR signaling 
may also suggest that the high fat diet suppressed insulin signaling in the intestinal 
epithelium, as observed in other tissues of diet-induced obese mice (47, 48). The potential 
depression of insulin signaling in the intestinal epithelium may contribute also to the 
increased PDK4 levels, as observed during starvation and in diabetes (14). 
 
Epithelial proliferation and apoptosis were not markedly changed in WD mice, although the 
ratio of proliferation to apoptosis showed a tendency (P = 0.098) to be lower. However, 
gene expression analysis showed a clear impact of the WD on both pro- and antiapoptotic 
pathways in the mucosa, suggesting a disturbance in the regulation of epithelial renewal. 
The proliferation/apoptosis ratio did not correlate with the number of adenomas, suggesting 
that the regulation of apoptosis as such is not the direct cause for increased adenoma 
number.   
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Mucosal β-catenin levels showed only a tendency towards elevation in the WD mice, and 
the gene expression data suggest that the Wnt pathway was rather attenuated than 
activated. This suggests that other functions of truncation of Apc in the WD mice, beside 
changes in β-catenin-regulated transcription, may explain the higher number of polyps. The 
location of a mutation in the Apc gene regulates the number of adenomas and the level of β-
catenin in epithelial tissue (49).  In comparison with the Min mutation, an Apc1322T mutation 
results in lower β-catenin levels in the enterocytes but a much higher total number of polyps 
(49). In our earlier study in the Min/+ mouse, β-catenin levels in adenomas were significantly 
associated with adenoma size but not number, demonstrating the active role of β-catenin in 
driving the growth of tumor tissue rather than promoting the initiation phase (50).  
 
All in all, our results suggest that a high-risk Western diet that is high in fat and low in 
calcium and vitamin D, primes the intestinal epithelium to tumorigenesis by changing tissue 
organization and programming a cancer-type energy metabolism together with induced 
oxidative stress, which accelerates the loss of Apc heterozygosity.  The synergistic effects of 
the genetic predisposition and the diet result in significantly accelerated intestinal 
tumorigenesis.   
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TABLES 
 
Table I: Composition of diets 
Component AIN-93G Western diet 
protein, %kcal 18.8 18.5 
CHO, %kcal 63.9 42.3 
fat, %kcal 
milk fat; %fat/ %diet 
oil; %fat/ %diet 
17.2 
- 
100/ 7.0 
39.2 
66.4/ 13.2 
33.6/ 6.7 
kcal/g 3.8 4.6 
Ca, g/kg 5.0 0.5 
folic acid, mg/kg 2.0 0.2 
vitamin D, IU/kg 1000 100 
 
 
Table 2. Enriched KEGG pathways at significance level of P < 0.05  
(±1.2 fold change) in the WD group as compared to the control group.  
 
KEGG Pathway Number of genes P - value
Starch and sucrose 
metabolism 
            5 0.0074 
Pyruvate metabolism 5 0.0012 
Glycolysis/Gluconeogenesis  6  0.0160 
PPAR signalling pathway 6 
 
0.0280 
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Table 3. Enriched GO biological processes the WD group as compared to the control group. 
Differences were considered significant at P < 0.05. 
 
GO pathway Number 
of genes 
P - value 
Oxidation reductation 29 0.0004 
Filopodium assembly  4 0.0009 
Microspike assembly 4 0.0013 
Regulation of apoptosis 23 0.0027 
Regulation of programmed cell death 23 0.0031 
Regulation of cell death 23 0.0034 
Fatty acid metabolic process 11 0.0051 
Hexose metabolic process 10 0.0088 
Glucose metabolic process 9 0.0088 
Regulation of transcription from RNA polymerase promoter 23 0.0094 
Cell projection assembly  6 0.0150 
Transmembrane transport 18 0.0160 
Monosaccharide metabolic process 10 0.0180 
Wnt receptor signaling pathway 8 0.0190 
Regulation of small GTPase mediated signal transduction 11 0.0210 
Muscle maintanence 3 0.0210 
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FIGURE LEGENDS  
 
Figure 1. The high-risk Western-type diet (WD) enhanced intestinal tumorigenesis and loss 
of APC heterozygosity in Min/+ mice (n = 12-14 per group). A. The mean number of 
adenomas in the small intestine was increased as compared to the AIN-93G control diet in a 
10-week feeding study. B. The diameter of adenomas did not differ. C. The ratio of the Min 
to the wild-type allele was significantly higher in the WD group and (D) correlated with 
adenoma numbers.  
 
Figure 2. The high-risk Western-type diet (WD) did not change (A) the proliferation or (B) 
apoptosis indexes in the mucosa of the small intestine in Min/+ mice (n = 12-14 per group), 
as compared to the AIN-93G control diet. C. The ratio between proliferation and apoptosis 
was, however lower on the WD diet. Examples of immunostainings for Ki67 antigen (D) and 
cleaved caspase 3 (E) are shown below. 
 
Figure 3. The high-risk Western-type diet (WD) induced changes in central pathways 
involved in carcinogenesis in Min/+ mice (n = 12-14 per group). The activation of the ERK (A), 
AKT (B) and mTOR  (C) pathways was suppressed in the WD mice as compared to the AIN-
93G mice as assessed by the relation of phosphorylated to total protein levels in Western 
blots. D. WD diet up-regulated PDK4 signaling reflected in higher PDK4 protein levels in the 
WD group. Representative examples of Western blots are shown below. 
 
Figure 4. The high-risk Western-type diet (WD) changes inflammatory status in the mucosa 
of Min/+ mice (n = 12-14 per group). The density of intraepithelial CD3ε+ T lymphocytes (A) 
and the density of mucosal FoxP3+ regulatory T cells (B) in the distal small intestine was 
increased in the WD group. The density of mucosal CD45R+ B lymphocytes did not differ 
significantly between the diet groups (C). Examples of immunostainings for these markers 
are shown below the boxplots. The number of adenomas correlated significantly with (D) 
the density of FoxP3+ cells and inversely with (E) the density of CD45R+ cell. 




